Senior > AMD

Enrollment complete in Graybug's phase 2b wet AMD treatment trial

14 days ago   |   Healio

The final patient has been enrolled in a phase 2b trial of Graybug Vision's wet age-related macular degeneration treatment candidate, according to a press release. The...
Read more ...

Visual acuity, injection frequency decrease over time in real-world AMD study

15 days ago   |   Healio

In a retrospective study, patients with neovascular age-related macular degeneration treated with anti-VEGF injections experienced decreased visual acuity from baseline and...
Read more ...

Tooth-enamel protein discovered in the eyes of people with dry AMD

19 days ago   |   News Medical

A protein that normally deposits mineralized calcium in tooth enamel may also be responsible for calcium deposits in the back of the eye in people with dry age-related macular...
Read more ...

Final visual outcomes worse after anti-VEGF treatment lapse

23 days ago   |   Healio

PHILADELPHIA - Patients with neovascular age-related macular degeneration receiving intravitreal anti-VEGF injections should be encouraged to adhere to their treatment regimen...
Read more ...

Santen, Tracon discontinue development of wet AMD treatment

23 days ago   |   Healio

Santen and Tracon Pharmaceuticals have discontinued development of DE-122, their wet age-related macular degeneration treatment candidate, following data analysis of a phase 2a...
Read more ...

VIDEO: AI leads patients through head-mounted AMD test

28 days ago   |   Healio

ATLANTA - Maculogix has taken the 45-pound tabletop dark adaptation testing device, AdaptDx, and turned it into a head-mounted technology managed by an onboard artificial...
Read more ...

Scientists make important discovery with implications for people living with AMD

1 month ago   |   News Medical   |   2 articles

Scientists from Trinity College Dublin have made an important discovery with implications for those living with a common, debilitating eye disease that can cause blindness.
Read more ...

Beovu approved for wet AMD in Europe

1 month ago   |   Healio

The European Commission has approved Beovu for the treatment of wet age-related macular degeneration, Novartis announced in a press release. Beovu is the first anti-VEGF...
Read more ...

Repeated injections for AMD increase glaucoma risk

1 month ago   |   Healio

Researchers in Wheaton, Ill., reported that patients with age-related macular degeneration were more likely to develop glaucoma and its risk factor, ocular hypertension, when...
Read more ...

Periodontal disease may be risk factor for AMD

1 month ago   |   Healio

Periodontal diseases are a possible additional risk factor for age-related macular degeneration; however, the link between the two remains unclear, according to a literature...
Read more ...


Register you to post on Health Mag

Free Registration

New Biomarker in Blood Helps Detect Alzheimer's Early

New Biomarker in Blood Helps Detect Alzheimer's Early

Discovery of new biomarker- RNA produced by the PHGDH gene in blood could lead to early test for Alzheimer's disease. Read more ...